These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 26056621

  • 1. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
    Wang N, Bu R, Duan Z, Zhang X, Chen P, Li Z, Wu J, Cai G, Chen X.
    PeerJ; 2015; 3():e990. PubMed ID: 26056621
    [Abstract] [Full Text] [Related]

  • 2. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
    Li S, Hao H, Li R, Guo S.
    Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
    [Abstract] [Full Text] [Related]

  • 3. Plasma microRNA signature of patients with IgA nephropathy.
    Wu J, Zhang H, Wang W, Zhu M, Qi LW, Wang T, Cheng W, Zhu J, Shan X, Huang Z, Zhang L, Chen Y, Sun B, Zhao X, Qian J, Zhu W, Zhou X, Xing C.
    Gene; 2018 Apr 05; 649():80-86. PubMed ID: 29459010
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH, Chen XM, Zou YQ, Zhang J, Li J, Wang Y, Li SQ, Gao QF, Sun F, Liu J, Xu YM, Lin J, Huang LF, Huang B, Wang XZ.
    J Clin Lab Anal; 2018 Feb 05; 32(2):. PubMed ID: 28383146
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, Zhu XJ, Liu FY.
    Ren Fail; 2012 Feb 05; 34(7):821-6. PubMed ID: 22679920
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K.
    Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628
    [Abstract] [Full Text] [Related]

  • 7. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM.
    Sci Rep; 2016 Mar 22; 6():23498. PubMed ID: 27000966
    [Abstract] [Full Text] [Related]

  • 8. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
    Zhang M, Duan ZY, Zhang QY, Xu XG, Zhang Y, Wang P, Duan SW, Wu J, Chen XM, Cai GY.
    Sci Rep; 2023 Apr 13; 13(1):6048. PubMed ID: 37055445
    [Abstract] [Full Text] [Related]

  • 9. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 10. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
    Liang Y, Zhao G, Tang L, Zhang J, Li T, Liu Z.
    Exp Cell Res; 2016 Oct 01; 347(2):312-21. PubMed ID: 27542871
    [Abstract] [Full Text] [Related]

  • 11. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
    Duan ZY, Bu R, Liang S, Chen XZ, Zhang C, Zhang QY, Li JJ, Chen XM, Cai GY.
    Front Immunol; 2024 Oct 01; 15():1326026. PubMed ID: 38426107
    [Abstract] [Full Text] [Related]

  • 12. Detection of microRNA-33a-5p in serum, urine and renal tissue of patients with IgA nephropathy.
    Liu L, Duan A, Guo Q, Sun G, Cui W, Lu X, Yu H, Luo P.
    Exp Ther Med; 2021 Mar 01; 21(3):205. PubMed ID: 33500698
    [Abstract] [Full Text] [Related]

  • 13. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y.
    BMC Immunol; 2018 Jun 20; 19(1):18. PubMed ID: 29925312
    [Abstract] [Full Text] [Related]

  • 14. Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy.
    Zhou G, Zhang X, Wang W, Zhang W, Wang H, Xin G.
    Med Sci Monit; 2019 Mar 13; 25():1903-1916. PubMed ID: 30865617
    [Abstract] [Full Text] [Related]

  • 15. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.
    Wang G, Kwan BC, Lai FM, Chow KM, Kam-Tao Li P, Szeto CC.
    Dis Markers; 2010 Mar 13; 28(2):79-86. PubMed ID: 20364043
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels.
    Duan A, Liu L, Lou Y, Zhang D, Li H, Chen Y, Cui W, Miao L.
    Clin Lab; 2019 Jul 01; 65(7):. PubMed ID: 31307184
    [Abstract] [Full Text] [Related]

  • 17. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.
    Hennino MF, Buob D, Van der Hauwaert C, Gnemmi V, Jomaa Z, Pottier N, Savary G, Drumez E, Noël C, Cauffiez C, Glowacki F.
    Sci Rep; 2016 Jun 06; 6():27209. PubMed ID: 27264483
    [Abstract] [Full Text] [Related]

  • 18. The increased miRNA-150-5p expression of the tonsil tissue in patients with IgA nephropathy may be related to the pathogenesis of disease.
    Xu Y, He Y, Hu H, Xu R, Liao Y, Dong X, Song H, Chen X, Chen J.
    Int Immunopharmacol; 2021 Nov 06; 100():108124. PubMed ID: 34600394
    [Abstract] [Full Text] [Related]

  • 19. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
    Hu H, Wan Q, Li T, Qi D, Dong X, Xu Y, Chen H, Liu H, Huang H, Wei C, Zhou W, Jiang S, Mo Z, Liao F, Xu Q, He Y.
    Iran J Kidney Dis; 2020 Mar 06; 14(2):107-118. PubMed ID: 32165595
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.
    Pawluczyk IZA, Didangelos A, Barbour SJ, Er L, Becker JU, Martin R, Taylor S, Bhachu JS, Lyons EG, Jenkins RH, Fraser D, Molyneux K, Perales-Patón J, Saez-Rodriguez J, Barratt J.
    Kidney Int; 2021 May 06; 99(5):1127-1139. PubMed ID: 33417998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.